For Journalists

The Massachusetts Biotechnology Council represents more than 550 biotechnology companies and organizations involved with the industry. We are available to comment and provide background on public policy, economic development, education, workforce development and other key life science issues.

John Heffernan
Media Contact
Vice President, Policy & External Affairs

Massachusetts Biotechnology Council
One Cambridge Center
Cambridge, MA 02142
617.674.5145
john.heffernan@massbio.org

MBC Members

View the 550 biotechnology companies, universities, academic institutions that make up our membership list.

Press Kit

Biotechnology in Massachusetts

Biotechnology, drug research based on biology rather than chemicals, emerged as an industry separate from traditional pharmaceuticals about 30 years ago. Massachusetts soon became a leader in the young field. After nearly three decades of growth, the state is one of the most significant centers in the world.

Key facts:

  • There are more than 400 biotechnology companies in the state, of which 235 are developing therapeutic drugs.
  • The industry employs nearly 43,000 people with a total payroll of more than $5 billion.
  • Massachusetts-based biopharmaceutical companies have already developed 50 large molecule drugs covering a range of illnesses.
  • There are nearly 1,769 biotechnology drugs being developed in Massachusetts, representing more than 7 percent of the global drug pipeline.
  • In 2006, Massachusetts venture capitalists invested almost $760 million in biotechnology companies, comprising 18% of biotechnology venture capital investment in the United States.

Upcoming Events